Prof. Dr. FUNDA ÜSTÜN

Rapor 2

Turkish Journal of Hematology

Rapor

26.01.2026

19-Oct-2025

Dear Dr. Üstün:

Thank you for reviewing manuscript # TJH-2025-0388 entitled "Role of ¹⁸F-FDG PET Metabolic Parameters in Treatment Response Evaluation and Prognostic Assessment of Hodgkin Lymphoma: A Retrospective Analysis" for the Turkish Journal of Hematology.

On behalf of the Editors of the Turkish Journal of Hematology, we appreciate the voluntary contribution that each reviewer gives to the Journal. We thank you for your participation in the online review process and hope that we may call upon you again to review future manuscripts.

Sincerely,
Dr. Meltem Akay
Associate Editor, Turkish Journal of Hematology
olga.akay@hotmail.com

Pamukkale Tıp Dergi review

Rapor

20.10.2025

https://dergipark.org.tr/en/journal/2240/article/1781904/reviewer/overview

Dear Funda Üstün,

The decision has been marked by editorial for the article titled "Differentiated Thyroid Carcinoma in Denizli Region: Demographic Data and Clinical Features from a Tertiary Center" that you reviewed.

Reviewer Decisions: Hakem A: Minör Revizyon (Siz)
Hakem B: Minör Revizyon

Editor Decision: Kabul Edildi

You can access your review via https://dergipark.org.tr/en/journal/2240/article/1781904/reviewer/overview

Best Regards,
Pamukkale Medical Journal

Sunum 1

Yeni Değerlendirme Kriterleri ile Lenfosintigrafi

Sunum

10.04.2025

Olgularla Tartışalım Oturumunda "Yeni Değerlendirme Kriterleri ile Lenfosintigrafié

nukleer-program 2.pdf

Diğer 1

Dear Colleagues, We kindly invite you to the “Conference of Trends for Radiopharmaceuticals in the Theranostic Era -2025- CTRTE-2025” organized with the collaboration of Turkish Radiopharmacy and Preclinal Working Groups. The series of Radiopharmacy Working Group meetings in Turkey began with the International Congress of Radiopharmacy and Radiopharmaceutical Chemistry (ICRRC'04) held in Istanbul on September 24-27, 2004, under the leadership of Dr. Hatice Durak, the 2004 President of the Turkish Nuclear Medicine Association, and continued with an international meeting in Izmir organized by Dr. Perihan Ünak, the President of the Radiopharmacy Working Group. The second meeting was held within the scope of the National Turkish Nuclear Medicine Congress in İzmir in 2016. This was chaired by Dr. Türkan Ertay titled as “Second National Radiopharmaceutical Sciences Congress". The third one was organized as a symposium online format titled “"Future Perspective of Radiopharmaceuticals in Nuclear Medicine" in 2023. We are organizing the forth meeting CTRTE-2025 with the collaboration of Turkish Radiopharmacy and Preclinal Working Groups to bring together world leading and junior scientists from the different branches of nuclear medicine working group research communities. The goal of Conference of Trends for Radiopharmaceuticals in the Theranostic Era -2025 will focus on scientists and other professionals working in production of radioisotopes and radiopharmaceuticals with an international forum to discuss the most recent developments and challenges in the field. The conference will be a great opportunity to expand contacts with scientists from all over the world working in physicians, (radio)chemists, (radio)pharmacists, biologists, physicists, technologists and other professionals working in the fields of production and uses of medical radioisotopes and radiopharmaceuticals. More detailed information is provided on the official website (www.radiothera2025.org) We will be honored with your participation and contribution to “Conference of Trends for Radiopharmaceuticals in the Theranostic Era -2025” which will be a great opportunity to meet with scientists from different countries around the world and sharing new and exciting results in radiopharmaceutical era. We are looking forward to seeing you in Izmir-TÜRKİYE on 24-25 April 2025.

Diğer

26.01.2026

https://www.radiothera2025.org/